Neurodevelopmental defects in Dravet syndrome Scn1a+/− mice: Targeting GABA-switch rescues behavioral dysfunctions but not seizures and mortality
Dravet syndrome (DS) is a developmental and epileptic encephalopathy (DEE) caused by mutations of the SCN1A gene (NaV1.1 sodium channel) and characterized by seizures, motor disabilities and cognitive/behavioral deficits, including autistic traits. The relative role of seizures and neurodevelopmenta...
Saved in:
| Main Authors: | Lara Pizzamiglio, Fabrizio Capitano, Evgeniia Rusina, Giuliana Fossati, Elisabetta Menna, Isabelle Léna, Flavia Antonucci, Massimo Mantegazza |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-04-01
|
| Series: | Neurobiology of Disease |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996125000695 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SCN1A gain of function effects in Dravet syndrome: Insights into clinical phenotypes and therapeutic implications
by: Yoko Kobayashi Takahashi, et al.
Published: (2025-08-01) -
Sodium channels as a new target for pain treatment
by: Rui Chen, et al.
Published: (2025-03-01) -
Role of nitric oxide synthase on brain GABA transaminase activity and GABA levels
by: Vega Rasgado Lourdes A., et al.
Published: (2018-09-01) -
Dravet syndrome: novel insights into SCN1A-mediated epileptic neurodevelopmental disorders within the molecular diagnostic-therapeutic framework
by: Guirui Zhang, et al.
Published: (2025-07-01) -
Breaking the pain barrier: how suzetrigine and selective sodium channel blockers are reshaping the future of opioid-free analgesia
by: Aleksandra Kaniak, et al.
Published: (2025-06-01)